Showing results (1-10 of 1,472) with videos related to
Sort By:
Pageof 148
Circulation. Cardiovascular Quality and Outcomes|March 5, 2024
Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 InterventionAnastasia Drakos, Tara McCready, Patricio Lopez-Jaramillo, et al.Journal of Translational Medicine|August 20, 2016
Could patents interfere with the development of a cardiovascular polypill?Reed F Beall, Jon-David R Schwalm, Mark D Huffman, et al.European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.The Canadian Journal of Cardiology|September 18, 2010
Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitusJohn A Cairns, Salim Yusuf, Richard J Cook, et al.Trials|February 22, 2011
Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working GroupLehana Thabane, George Wells, Richard Cook, et al.CJC Open|March 29, 2021
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot StudyJon-David Schwalm, Tara McCready, Scott A Lear, et al.Statistics in Medicine|September 27, 2002
Clinical research and trials in developing countriesSalim YusufThe American Journal of Cardiology|February 12, 2002
From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosisSalim YusufPlos One|April 25, 2015
Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative studyHelena Legido-Quigley, Paul Anthony Camacho Lopez, Dina Balabanova, et al.American Heart Journal|January 5, 2002
Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes?Salim Yusuf, Abdissa NegassaPageof 148